Products for Research Use Only
RegisterLogin

DZ2002

CAT: 0804-HY-18620-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-18620-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DZ2002 is an orally active, reversible and low-cytotoxic type III SAHH inhibitor (Ki=17.9 nM), with good immunosuppressive activity. DZ2002 prevents the development of experimental dermal fibrosis by reversing the profibrotic phenotype of various cell types. DZ2002 can be used in studies of autoimmune diseases such as lupus syndrome and systemic sclerosis[1][2].
CAS Number
33231-14-0
UNSPSC
12352005
Target
Akt; Antibiotic; Bacterial; ERK; MEK; NF-κB; PI3K; STAT
Type
Reference compound
Related Pathways
Anti-infection; JAK/STAT Signaling; MAPK/ERK Pathway; NF-κB; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/DZ2002.html
Purity
99.83
Solubility
DMSO : ≥ 61 mg/mL
Smiles
OC(C(OC)=O)CCN1C(N=CN=C2N)=C2N=C1
Molecular Formula
C10H13N5O3
Molecular Weight
251.25
References & Citations
[1]Wu QL, et al. Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression. J Pharmacol Exp Ther. 2005 May;313 (2) :705-11. |[2]Zhang Z, et al. DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models. Arthritis Res Ther. 2019 Dec 16;21 (1) :290.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
T11134-01DZ2002
A20912-100DZ2002 100mg
A20912-5DZ2002 5mg
A20912-50DZ2002 50mg
A20912-10DZ2002 10mg
A20912-500DZ2002 500mg
A20912-25DZ2002 25mg
A20912-1DZ2002 1mg
A20912-10mM-DDZ2002 10mM * 1mL in DMSO

Popular Products